569 related articles for article (PubMed ID: 9663234)
21. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N
J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306
[TBL] [Abstract][Full Text] [Related]
22. Guillain-Barré syndrome and Fisher's syndrome following Campylobacter jejuni infection.
Yuki N; Miyatake T
Ann N Y Acad Sci; 1998 Jun; 845():330-40. PubMed ID: 9668366
[TBL] [Abstract][Full Text] [Related]
23. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders.
Enders U; Karch H; Toyka KV; Michels M; Zielasek J; Pette M; Heesemann J; Hartung HP
Ann Neurol; 1993 Aug; 34(2):136-44. PubMed ID: 8338338
[TBL] [Abstract][Full Text] [Related]
24. Association study between an outbreak of Guillain-Barre syndrome in Jilin, China, and preceding Campylobacter jejuni infection.
Zhang M; Li Q; He L; Meng F; Gu Y; Zheng M; Gong Y; Wang P; Ruan F; Zhou L; Wu J; Chen L; Fitzgerald C; Zhang J
Foodborne Pathog Dis; 2010 Aug; 7(8):913-9. PubMed ID: 20455754
[TBL] [Abstract][Full Text] [Related]
25. [Guillain-Barré syndrome associated Campylobacter jejuni serogroup Penner A showing antecedent fever and abdominal pain without diarrhea].
Fukushima T; Yukawa T; Makino K; Matsubara N; Yamazaki M
No To Shinkei; 2005 Oct; 57(10):889-92. PubMed ID: 16277234
[TBL] [Abstract][Full Text] [Related]
26. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes.
Koga M; Yuki N; Takahashi M; Saito K; Hirata K
J Neuroimmunol; 1998 Jan; 81(1-2):138-43. PubMed ID: 9521615
[TBL] [Abstract][Full Text] [Related]
27. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
[TBL] [Abstract][Full Text] [Related]
28. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
Tagawa Y; Matsumoto Y; Yuki N
No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
[TBL] [Abstract][Full Text] [Related]
29. Continuous spectrum of pharyngeal-cervical-brachial variant of Guillain-Barré syndrome.
Nagashima T; Koga M; Odaka M; Hirata K; Yuki N
Arch Neurol; 2007 Oct; 64(10):1519-23. PubMed ID: 17923636
[TBL] [Abstract][Full Text] [Related]
30. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
[TBL] [Abstract][Full Text] [Related]
31. [Antibody response following Campylobacter infections determined by ELISA].
Engberg JH; Strid MA; Mølbak K; Krogfelt KA
Ugeskr Laeger; 2003 Jun; 165(24):2485-6. PubMed ID: 12872469
[TBL] [Abstract][Full Text] [Related]
32. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
[TBL] [Abstract][Full Text] [Related]
33. Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2-year follow-up study of 210 patients.
Strid MA; Engberg J; Larsen LB; Begtrup K; Mølbak K; Krogfelt KA
Clin Diagn Lab Immunol; 2001 Mar; 8(2):314-9. PubMed ID: 11238214
[TBL] [Abstract][Full Text] [Related]
34. Recognition characteristics of monoclonal antibodies that are cross-reactive with gangliosides and lipooligosaccharide from Campylobacter jejuni strains associated with Guillain-Barré and Fisher syndromes.
Houliston RS; Yuki N; Hirama T; Khieu NH; Brisson JR; Gilbert M; Jarrell HC
Biochemistry; 2007 Jan; 46(1):36-44. PubMed ID: 17198373
[TBL] [Abstract][Full Text] [Related]
35. Bickerstaff's brainstem encephalitis after an outbreak of Campylobacter jejuni enteritis.
Mori M; Koga M; Yuki N; Hattori T; Kuwabara S
J Neuroimmunol; 2008 May; 196(1-2):143-6. PubMed ID: 18406474
[TBL] [Abstract][Full Text] [Related]
36. [Fisher's syndrome following Campylobacter jejuni enteritis--a case report and review of the literature].
Ichikawa H; Sugita K; Fukui T; Saito K; Yuki N
Rinsho Shinkeigaku; 1995 Apr; 35(4):391-5. PubMed ID: 7614765
[TBL] [Abstract][Full Text] [Related]
37. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry.
Oomes PG; Jacobs BC; Hazenberg MP; Bänffer JR; van der Meché FG
Ann Neurol; 1995 Aug; 38(2):170-5. PubMed ID: 7654064
[TBL] [Abstract][Full Text] [Related]
38. Is Campylobacter lipopolysaccharide bearing a GD3 epitope essential for the pathogenesis of Guillain-Barré syndrome?
Yuki N; Koga M; Hirata K
Acta Neurol Scand; 2000 Aug; 102(2):132-4. PubMed ID: 10949532
[TBL] [Abstract][Full Text] [Related]
39. Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections.
Hao Q; Saida T; Kuroki S; Nishimura M; Nukina M; Obayashi H; Saida K
J Neuroimmunol; 1998 Jan; 81(1-2):116-26. PubMed ID: 9521613
[TBL] [Abstract][Full Text] [Related]
40. Human and chicken antibodies to gangliosides following infection by Campylobacter jejuni.
Usuki S; Taguchi K; Cawthraw SA; Shibata K; Ariga T; Newell DG; Yu RK
Exp Neurol; 2006 Jul; 200(1):50-5. PubMed ID: 16500643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
